-
New study quantifies the annual cost of dementia at $818 billion, with families picking up most of the tab
A new study puts the total U.S. cost of dementia at $818 billion for 2026, but only 27% of that…
-
Reporter uncovers how drug companies ‘make’ people into Alzheimer’s patients
Jeanne Lenzer shows how she discovered drug companies recruit people into taking Alzheimer’s blood tests which may cause more harm…
-
What to know about the geriatric workforce shortage
The health care system wasn’t built to handle the projected increase in older adults, and there aren’t enough geriatricians to…
-
GLP-1s are different for older adults
GLP-1 access for obesity will get easier for Medicare beneficiaries as of July 1 — but they can have serious…
-
Policy experts offer differing views on health care for all at HJ26
During Thursday’s plenary at Health Journalism 2026, policy experts discussed whether the government should guarantee health care for all.
-
Medicare and Medicaid will cover weight-loss drugs next year
The Medicare GLP-1 Bridge program will operate outside Part D benefit’s coverage and payment flow, so part D insurers don’t…
-
How NIH-funded AI research could change aging in America
Across the U.S., researchers are working on numerous AI-based research projects that could improve care and health outcomes for older…
-
Study reframes aging narrative: Many older adults improve in later life
A new Yale University study challenges a common assumption around aging: that later life means inevitable cognitive and physical decline.
-
Race and risk in menopause: The connection journalists miss
Menopause is often discussed only in terms of hot flashes and mood changes — but research shows that it is a…
-
A simple blood test could detect Alzheimer’s earlier, but Medicare doesn’t cover it
Medicare doesn’t cover new FDA-approved blood tests that could detect Alzheimer’s early. The bipartisan “ASAP Act” aims to change that.